中国医学装备
中國醫學裝備
중국의학장비
China Medical Equipment
2015年
11期
102-104,105
,共4页
乳腺占位%超声%穿刺活检
乳腺佔位%超聲%穿刺活檢
유선점위%초성%천자활검
Breast lesion%Ultrasound%Biopsy
目的：评估型号为18 G和16 G穿刺活检针在乳腺占位病变诊断中的价值。方法：对115例外科手术切除的乳腺占位患者，术前行超声检查，并在超声引导下采用18 G和16 G穿刺活检针各取材2次送病检。外科手术切除术后，再行术后病理组织学检查，比较两种不同直径的穿刺活检针在乳腺良恶性占位诊断的灵敏度、特异度及假阴性率。结果：手术切除后病理诊断的84例乳腺癌患者中，18 G穿刺针活检病理诊断的灵敏度、特异度及假阴性率分别为95.2%、100%及4.8%；16 G穿刺针活检病理诊断的灵敏度、特异度及假阴性率分别为97.6%、100%及2.4%。18 G和16 G穿刺活检针取材活检病理结果比较差异无统计学意义(x2=108.42，P＞0.05)。结论：18 G和16 G穿刺活检针取材的一致性，经病理证实无明显统计学差异。
目的：評估型號為18 G和16 G穿刺活檢針在乳腺佔位病變診斷中的價值。方法：對115例外科手術切除的乳腺佔位患者，術前行超聲檢查，併在超聲引導下採用18 G和16 G穿刺活檢針各取材2次送病檢。外科手術切除術後，再行術後病理組織學檢查，比較兩種不同直徑的穿刺活檢針在乳腺良噁性佔位診斷的靈敏度、特異度及假陰性率。結果：手術切除後病理診斷的84例乳腺癌患者中，18 G穿刺針活檢病理診斷的靈敏度、特異度及假陰性率分彆為95.2%、100%及4.8%；16 G穿刺針活檢病理診斷的靈敏度、特異度及假陰性率分彆為97.6%、100%及2.4%。18 G和16 G穿刺活檢針取材活檢病理結果比較差異無統計學意義(x2=108.42，P＞0.05)。結論：18 G和16 G穿刺活檢針取材的一緻性，經病理證實無明顯統計學差異。
목적：평고형호위18 G화16 G천자활검침재유선점위병변진단중적개치。방법：대115예외과수술절제적유선점위환자，술전행초성검사，병재초성인도하채용18 G화16 G천자활검침각취재2차송병검。외과수술절제술후，재행술후병리조직학검사，비교량충불동직경적천자활검침재유선량악성점위진단적령민도、특이도급가음성솔。결과：수술절제후병리진단적84례유선암환자중，18 G천자침활검병리진단적령민도、특이도급가음성솔분별위95.2%、100%급4.8%；16 G천자침활검병리진단적령민도、특이도급가음성솔분별위97.6%、100%급2.4%。18 G화16 G천자활검침취재활검병리결과비교차이무통계학의의(x2=108.42，P＞0.05)。결론：18 G화16 G천자활검침취재적일치성，경병리증실무명현통계학차이。
Objective:To evaluate the diagnostic value of 18G and 16G needle biopsy of breast lesions.Methods: Onr hundred and fifteen patients with breast lesions those were excised through surgery. Each lesion was under ultrasound-guided needle biopsy(US-CNB) with 18G and 16G, then underwent surgical resection of mass and pathological histology. Histological findings of US-CNB and the surgical specimens were analyzed for sensitivities, false negative rates, and underestimate rates.Results: Among 84 cases of breast cancer proved by surgical pathology, the sensitivity, specificity, false negative rate of 18G and 16G biopsy diagnosis were followed by 95.2% and 97.6%, 89.6% and 94.3%, 4.8% and 2.4%. Paired chi-square test showed no significant difference between the two methods.Conclusion: 18G and 16G needle biopsy has no significant difference in the diagnosis of breast lesions.
